In the latest trading session,, 0.42 million Zhengye Biotechnology Holding Ltd (NASDAQ:ZYBT) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $6.69 changing hands around $1.53 or 29.65% at last look, the market valuation stands at $317.04M. ZYBT’s current price is a discount, trading about -113.75% off its 52-week high of $14.30. The share price had its 52-week low at $3.50, which suggests the last value was 47.68% up since then. When we look at Zhengye Biotechnology Holding Ltd’s average trading volume, we note the 10-day average is 0.58 million shares, with the 3-month average coming to 554.94K.

Zhengye Biotechnology Holding Ltd (NASDAQ:ZYBT) trade information

Instantly ZYBT is in green as seen in intraday trades today. With action -5.91%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 37.65%, with the 5-day performance at -5.91% in the red. However, in the 30-day time frame, Zhengye Biotechnology Holding Ltd (NASDAQ:ZYBT) is -35.11% down. Looking at the short shares, we see there were 0.13 million shares sold at short interest cover period of 0.19 days.

ZYBT Dividends

Zhengye Biotechnology Holding Ltd is expected to release its next quarterly earnings report in July.

Zhengye Biotechnology Holding Ltd (NASDAQ:ZYBT)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 91.64% of Zhengye Biotechnology Holding Ltd shares while 0.02% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 0.25%.

With 8.45 shares estimated at $55416.0 under it, the former controlled 0.02% of total outstanding shares.